+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Circulating Tumor Cell Market by Technology Type, Product Type, Application, Cancer Type, End Users - Global Forecast to 2030- Product Image
Circulating Tumor Cell Market by Technology Type, Product Type, Application, Cancer Type, End Users - Global Forecast to 2030- Product Image
Sale

Circulating Tumor Cell Market by Technology Type, Product Type, Application, Cancer Type, End Users - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5311178
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The circulating tumor cell market is experiencing rapid transformation, driven by technological advances that are reshaping how cancer is diagnosed, monitored, and managed. Senior decision-makers evaluating this sector will find a landscape marked by innovation, evolving partnerships, and dynamic global trends, positioning circulating tumor cell (CTC) technologies as pivotal to the future of precision oncology.

Market Snapshot: Circulating Tumor Cell Market Growth and Outlook

The Circulating Tumor Cell Market grew from USD 12.82 billion in 2024 to USD 14.10 billion in 2025, and is projected to continue expanding at a CAGR of 10.25%, reaching USD 23.02 billion by 2030. This strong growth reflects heightened demand for earlier cancer detection, real-time monitoring, and personalized patient management, supported by advances in CTC-based assays and broadening investment from both industry and clinical sectors.

Scope & Segmentation

This research provides a comprehensive analysis across multiple dimensions of the CTC landscape. Segmentation enables organizations to tailor their strategies, ensuring relevant market positioning and competitive advantage.

  • Technology Type: CTC analysis, CTC detection and isolation methods, including immunomagnetic separation and microfluidic-based platforms.
  • Product Type: Instruments dedicated to automated or high-throughput CTC workflows; kits and reagents supporting sample processing and analytical accuracy.
  • Application: Clinical diagnostics and research; drug development activities utilizing CTC assays for patient stratification and response monitoring.
  • Cancer Type: Breast, colorectal, lung, and prostate cancers, with growing clinical relevance in established and emerging indications.
  • End Users: Diagnostic centers, hospitals and clinics, research and academic institutes—each with distinct operational needs and workflow integration realities.
  • Geography: Americas (key US states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (major European economies and strategic markets across EMEA), Asia-Pacific (China, India, Japan, Australia, South Korea, and other dynamic countries driving regional growth).
  • Major Companies: Analysis covers market activities and developments of leading corporations and innovators such as Advanced Cell Diagnostics, Bio-Techne, Epic Sciences, Menarini Silicon Biosystems, Thermo Fisher Scientific, and others actively shaping the global competitive landscape.

Key Takeaways for Decision-Makers

  • Accelerated adoption of circulating tumor cell assays is evident in both research and clinical practice, contributing to the mainstreaming of precision oncology solutions among key clinical stakeholders.
  • Emerging technologies such as microfluidics and single-cell molecular profiling are enabling more sensitive, specific, and actionable insights from each isolated circulating tumor cell, deepening the understanding of tumor heterogeneity and resistance.
  • Strategic collaborations between diagnostic firms, pharmaceutical companies, and academic research centers are fundamental to integrating CTC analytics into clinical trial design and routine care.
  • The market is responding to increased global demand with a diversification of suppliers and a focus on modular platform architectures, supporting scalability and regulatory compliance across geographic markets.
  • End-user requirements are driving the development of turnkey, high-throughput solutions for diagnostics centers and hospitals, while modular and expandable platforms support innovation in research settings.
  • Geographic differences in regulatory frameworks, reimbursement models, and healthcare investment continue to influence the pace and nature of CTC technology adoption worldwide.

Tariff Impact: Adjusting to U.S. Policy Changes

The introduction of revised United States tariffs in 2025 on imported reagents, microfluidic chips, and specialized instruments has prompted CTC manufacturers and end users to reconfigure supply chains. Companies are accelerating localization of production, diversifying suppliers, and adopting alternative materials to balance cost pressures and maintain consistent product quality. The response across the CTC value chain underscores resilience and adaptability, ensuring continued market progression.

Methodology & Data Sources

This analysis combines primary interviews with key scientific and industry experts, robust quantitative surveys of end users, and secondary validation from regulatory databases, patent filings, and peer-reviewed publications. Triangulation through expert panels and validation workshops ensures data accuracy and reliability throughout the research process.

Why This Report Matters

  • Enables leaders to identify and adapt to disruptive trends by providing clear insights into emerging CTC technologies and strategies across regional markets.
  • Informs investment and partnership decisions with actionable intelligence on product portfolios, regulatory environments, and optimal commercialization pathways.
  • Equips decision-makers with an evidence-based foundation to align business strategy with evolving market drivers and clinical needs in oncology.

Conclusion

The circulating tumor cell market demonstrates robust growth and adaptability amidst technological, regulatory, and geopolitical shifts. Leaders leveraging these insights will be well positioned to advance oncology innovation, streamline value creation, and support improved outcomes in cancer care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Circulating Tumor Cell Market, by Technology Type
8.1. Introduction
8.2. CTC Analysis
8.3. CTC Detection & Isolation
8.3.1. Immunomagnetic Separation
8.3.2. Microfluidic-Based Separation
9. Circulating Tumor Cell Market, by Product Type
9.1. Introduction
9.2. Instruments
9.3. Kits & Reagents
10. Circulating Tumor Cell Market, by Application
10.1. Introduction
10.2. Clinical Diagnostics & Research
10.3. Drug Development
11. Circulating Tumor Cell Market, by Cancer Type
11.1. Introduction
11.2. Breast Cancer
11.3. Colorectal Cancer
11.4. Lung Cancer
11.5. Prostate Cancer
12. Circulating Tumor Cell Market, by End Users
12.1. Introduction
12.2. Diagnostic Centers
12.3. Hospital & Clinics
12.4. Research & Academic Institutes
13. Americas Circulating Tumor Cell Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Circulating Tumor Cell Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Circulating Tumor Cell Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Advanced Cell Diagnostics, Inc.
16.3.2. Bio-Techne Corporation
16.3.3. BioFluidica
16.3.4. Biolidics Limited
16.3.5. Creatv MicroTech, Inc.
16.3.6. Epic Sciences
16.3.7. Fluxion Biosciences, Inc. by Cell Microsystems
16.3.8. Greiner Bio-One International GmbH
16.3.9. Ikonisys, Inc.
16.3.10. LungLife AI, Inc.
16.3.11. Menarini Silicon Biosystems
16.3.12. Miltenyi Biotec GmbH
16.3.13. Precision Medicine Group, LLC
16.3.14. QIAGEN N.V.
16.3.15. Rarecells Diagnostics
16.3.16. ScreenCell
16.3.17. SRI International
16.3.18. STEMCELL Technologies, Inc.
16.3.19. Sysmex Corporation
16.3.20. Thermo Fisher Scientific Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CIRCULATING TUMOR CELL MARKET MULTI-CURRENCY
FIGURE 2. CIRCULATING TUMOR CELL MARKET MULTI-LANGUAGE
FIGURE 3. CIRCULATING TUMOR CELL MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CIRCULATING TUMOR CELL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CIRCULATING TUMOR CELL MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CIRCULATING TUMOR CELL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOMAGNETIC SEPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED SEPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL DIAGNOSTICS & RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 42. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 46. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 47. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 49. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 52. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 73. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 74. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 78. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 79. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 80. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 83. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 84. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 85. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 86. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 89. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 90. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 91. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 92. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 96. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 97. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 98. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 102. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 103. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 104. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 105. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 107. SPAIN CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 108. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 109. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 110. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 114. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 115. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 116. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 120. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 126. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 127. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 128. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 131. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 138. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 139. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 140. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 143. QATAR CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 144. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 145. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 146. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 149. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 150. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 151. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 152. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 156. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 157. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 158. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 162. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 163. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 164. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 167. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 168. TURKEY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 169. TURKEY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 170. TURKEY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. TURKEY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. TURKEY CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 173. TURKEY CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 174. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 175. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 176. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 180. NORWAY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 181. NORWAY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 182. NORWAY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. NORWAY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. NORWAY CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 185. NORWAY CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 186. POLAND CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 187. POLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 188. POLAND CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. POLAND CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. POLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 191. POLAND CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 192. SWITZERLAND CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 193. SWITZERLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 194. SWITZERLAND CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 205. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 206. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 207. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 210. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 211. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 212. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 213. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 216. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 217. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 218. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 219. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 222. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 229. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 230. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 235. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 236. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 237. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 241. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 242. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 243. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 246. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 247. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 248. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 249. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 253. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 254. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 255. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 259. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 260. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 261. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 265. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 266. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 267. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ISOLATION, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 277. CIRCULATING TUMOR CELL MARKET SHARE, BY KEY PLAYER, 2024
TABLE 278. CIRCULATING TUMOR CELL MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Circulating Tumor Cell market report include:
  • Advanced Cell Diagnostics, Inc.
  • Bio-Techne Corporation
  • BioFluidica
  • Biolidics Limited
  • Creatv MicroTech, Inc.
  • Epic Sciences
  • Fluxion Biosciences, Inc. by Cell Microsystems
  • Greiner Bio-One International GmbH
  • Ikonisys, Inc.
  • LungLife AI, Inc.
  • Menarini Silicon Biosystems
  • Miltenyi Biotec GmbH
  • Precision Medicine Group, LLC
  • QIAGEN N.V.
  • Rarecells Diagnostics
  • ScreenCell
  • SRI International
  • STEMCELL Technologies, Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages183
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 14.1 Billion
Forecasted Market Value ( USD ) by 2030 $ 23.02 Billion
Compound Annual Growth Rate10.2%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Circulating Tumor Cells Market Size, Share & Trends Analysis Report By Application (Clinical, Research), By Specimen (Bone Marrow, Blood), By Product, By Technology, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Circulating Tumor Cells Market Size, Share & Trends Analysis Report By Application (Clinical, Research), By Specimen (Bone Marrow, Blood), By Product, By Technology, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2025-2033 - Product Image

Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From
Circulating Tumor Cells Patent Landscape Report and Forecast 2024-2032 - Product Image

Circulating Tumor Cells Patent Landscape Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Circulating Tumor Cell (CTC) Diagnostics - Global Strategic Business Report - Product Image

Circulating Tumor Cell (CTC) Diagnostics - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Circulating Tumor Cells Market Report 2025 - Product Image

Circulating Tumor Cells Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Circulating Tumor Cell Market

Circulating Tumor Cells (CTCs) are a type of biomarker used to detect and monitor cancer. CTCs are cells that have been shed from a tumor and are present in the bloodstream. They can be used to diagnose cancer, monitor its progression, and assess the effectiveness of treatments. CTCs are also used to identify new therapeutic targets and to develop personalized treatments. CTCs are a rapidly growing market, with a range of products and services available to researchers and clinicians. Companies in the CTC market offer technologies for isolating, analyzing, and characterizing CTCs, as well as services for CTC-based diagnostics and drug development. Examples of companies in the CTC market include ApoCell, Menarini Silicon Biosystems, and RareCyte. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.